M1

M1 Kliniken AGXETRA M1 Stock Report

Last reporting period 31 Dec, 2023

Updated 18 Sep, 2024

Last price

Market cap $B

0.381

Micro

Exchange

XETR - Xetra

M12.DE Stock Analysis

M1

Neutral

Based on Eyestock quantitative analysis, M12.DE`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

67/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-23.2 %

Overvalued

Market cap $B

0.381

Dividend yield

2.87 %

Shares outstanding

18.58 B

M1 Kliniken AG engages in the provision of medical services in the field of beauty sector. The company is headquartered in Berlin, Berlin and currently employs 282 full-time employees. The company went IPO on 2015-09-14. The firm operates a chain of medical centers for aesthetic and plastic treatments, such as wrinkle treatments, lip treatments, breast corrections, liposuction, tummy tucks, upper arm lift, upper thigh lift, face lift, upper eyelid lift and the correction of labia, among others. In addition, the Company provides consultation services with registered doctors and specialists. The company operates medical centers in Berlin, Essen, Dusseldorf, Cologne and Munich.

View Section: Eyestock Rating